A baby with a rare and life-threatening disease has been helped by personalized gene editing, specifically a CRISPR gene editing therapy. The success of this treatment has raised questions about the potential for widespread use, with researchers planning to launch new clinical trials for rare diseases and the FDA expressing interest in individualized medicines. The development of this gene-editing tool may have implications for treating a range of genetic diseases.